RESUMEN
Glioblastoma is a lethal form of brain tumour usually treated by surgical resection followed by radiotherapy and an alkylating chemotherapeutic agent. Key to the success of this multimodal approach is maintaining apoptotic sensitivity of tumour cells to the alkylating agent. This initial treatment likely establishes conditions contributing to development of drug resistance as alkylating agents form the O6-methylguanine adduct. This activates the mismatch repair (MMR) process inducing apoptosis and mutagenesis. This review describes key juxtaposed drivers in the balance between alkylation induced mutagenesis and apoptosis. Mutations in MMR genes are the probable drivers for alkylation based drug resistance. Critical to this interaction are the dose-response and temporal interactions between adduct formation and MMR mutations. The precision in dose interval, dose-responses and temporal relationships dictate a role for alkylating agents in either promoting experimental tumour formation or inducing tumour cell death with chemotherapy. Importantly, this resultant loss of chemotherapeutic selective pressure provides opportunity to explore novel therapeutics and appropriate combinations to minimise alkylation based drug resistance and tumour relapse.
Asunto(s)
Aductos de ADN/genética , Resistencia a Antineoplásicos/genética , Glioblastoma/tratamiento farmacológico , Recurrencia Local de Neoplasia/tratamiento farmacológico , Antineoplásicos Alquilantes/efectos adversos , Antineoplásicos Alquilantes/uso terapéutico , Apoptosis/genética , Reparación de la Incompatibilidad de ADN/genética , Reparación del ADN/genética , Glioblastoma/genética , Glioblastoma/patología , Guanina/análogos & derivados , Guanina/metabolismo , Humanos , Mutación/genética , Recurrencia Local de Neoplasia/genética , Recurrencia Local de Neoplasia/patologíaRESUMEN
In this study, the vasodilatory actions of nine edible tropical plant extracts were investigated. Ipomoea batatas (sweet potato leaf), Piper betle (betel leaf), Anacardium occidentale (cashew leaf), Gynandropsis gynandra (maman leaf), Carica papaya (papaya leaf), and Mentha arvensis (mint leaf) extracts exhibited more than 50% relaxing effect on aortic ring preparations, while Piper betle and Cymbopogon citratus (lemongrass stalk) showed comparable vasorelaxation on isolated perfused mesenteric artery preparation. The vascular effect on the aortic ring preparations were mainly endothelium-dependent, and mediated by nitric oxide (NO) as supported by the inhibition of action in the presence of N(omega)-nitro-L-arginine (NOLA), an nitric oxide synthase (NOS) inhibitor, or by the removal of endothelium. In contrast, vasodilatory actions in resistance vessels (perfused mesenteric vascular beds) appear to involve several biochemical mediators, including NO, prostanoids, and endothelium-dependent hyperpolarizing factors (EDHFs). Total phenolic contents and antioxidant capacities varied among different extracts and found to be independent of vascular relaxation effects. This study demonstrates that many edible plants common in Asian diets to possess potential health benefits, affording protection at the vascular endothelium level.
Asunto(s)
Aorta Torácica/efectos de los fármacos , Arterias Mesentéricas/efectos de los fármacos , Plantas Comestibles/química , Plantas Medicinales/química , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacología , Animales , Técnicas In Vitro , Malasia , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Ratas , Ratas Endogámicas WKY , Clima Tropical , Vasodilatadores/aislamiento & purificaciónRESUMEN
The cardiovascular health benefits of longchain n-3 polyunsaturated fatty acids (PUFAs) have been reported to exert at several different cellular control mechanisms. These include, effects on lipoprotein metabolism, haemostatic function, platelet/vessel wall interactions, anti-arrhythmic actions and also inhibition of proliferation of smooth muscle cells and therefore growth of the atherosclerotic plaque. Fish oil feeding has also been found to result in moderate reductions in blood pressure and to modify vascular neuroeffector mechanisms. The majority of such cardiovascular benefits of n-3 PUFAs are likely to be mediated in the vascular wall and at the vascular endothelium level, since this monolayer of cells plays a central role in the regulation and maintenance of cardiovascular homeostasis and function. While these processes include endothelium-derived vasorelaxant and vasoconstrictor compounds, the vascular endothelium also plays host to many receptors, binding proteins, transporters and signalling mechanisms. Accordingly, endothelial dysfunction, which underlies many cardiovascular disease conditions, can trigger acute vascular events including vasospasm, thrombosis or restenosis leading to ischaemia. The longchain n-3 PUFAs have been reported to possess several properties that may positively influence vascular function. These include favourable mediator profiles (nitric oxide, eicosanoids) that influence vascular reactivity, change in vascular tone via actions on selective ion channels, and maintenance of vascular integrity. In addition to direct effects on contractility, n-3 PUFAs may affect vascular function, and the process of atherogenesis, via inhibition of vascular smooth muscle cell proliferation at the gene expression level, and by modifying expression of inflammatory cytokinesis and adhesion molecules. Collectively, these properties are consistent with pleiotropic actions of longchain n-3 PUFAs, and may explain the beneficial cardiovascular protection of this family of fatty acids that have been clearly evident through epidemiological data as well from more recent large-scale clinical trials.
Asunto(s)
Enfermedades Cardiovasculares/fisiopatología , Vasos Coronarios/fisiopatología , Ácidos Grasos Omega-3/farmacología , Vasoconstricción/efectos de los fármacos , Antiarrítmicos , Arteriosclerosis/tratamiento farmacológico , Arteriosclerosis/metabolismo , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/metabolismo , Moléculas de Adhesión Celular/metabolismo , División Celular , Vasos Coronarios/efectos de los fármacos , Citocinas/metabolismo , Eicosanoides/metabolismo , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Epoprostenol/metabolismo , Ácidos Grasos Omega-3/metabolismo , Ácidos Grasos Omega-3/uso terapéutico , Fibrinolíticos , Humanos , Canales Iónicos/efectos de los fármacos , Canales Iónicos/metabolismo , Leucocitos/patología , Contracción Miocárdica/efectos de los fármacos , Óxido Nítrico/metabolismoRESUMEN
Two currently available edible oils-olive and canola-and two oil blends of plant origin having different n-3/n-6 polyunsaturated fatty acid (PUFA) ratios were evaluated for their ability to modify vascular dysfunction in the spontaneously hypertensive rat (SHR). Synthetic diets supplemented with test oils (5% w/w) were fed for 12 weeks, and segments of thoracic aorta used to assess vascular function. Vessels from the SHR displayed a spontaneous constrictor response after the inhibition of endothelial cell nitric oxide (NO) with N(omega)-nitro-L-arginine (NOLA). Dietary alpha -linoleate enrichment led to a reduction (P<0.05) in this abnormality with a dietary n-3/n-6 PUFA ratio of 1.0 (blend-1) yielding the best outcome. Relaxation to acetylcholine (ACh) was unaffected by dietary lipid supplementation. NOLA treated rings also displayed contractions to ACh that were abolished by indomethacin, thromboxane antagonists SQ29548, picotamide and flavonoids kaempferol and quercetin. In contrast, alpha-tocopherol, rutin and the lipoxygenase inhibitor esculetin resulted in only partial (30-55%) inhibition, and were ineffective against the NOLA-induced contraction suggesting the operation of different biochemical mechanisms in mediating the spontaneous and Ach-induced contractions. Results implicate plant-based oils and antioxidants as potential modulators of vascular function.
Asunto(s)
Antioxidantes/metabolismo , Dieta , Ácidos Grasos Insaturados/metabolismo , Hipertensión/prevención & control , Quempferoles , Quercetina/análogos & derivados , Acetilcolina/antagonistas & inhibidores , Acetilcolina/farmacología , Animales , Antioxidantes/farmacología , Aorta/metabolismo , Compuestos Bicíclicos Heterocíclicos con Puentes , Fármacos Cardiovasculares/farmacología , Relación Dosis-Respuesta a Droga , Endotelio Vascular/metabolismo , Flavonoides/farmacología , Hidrazinas/farmacología , Indometacina/farmacología , Metabolismo de los Lípidos , Óxido Nítrico/metabolismo , Ácidos Ftálicos/farmacología , Aceites de Plantas/uso terapéutico , Inhibidores de Agregación Plaquetaria/farmacología , Quercetina/farmacología , Ratas , Ratas Endogámicas SHR , Rutina/farmacología , Umbeliferonas/farmacología , alfa-Tocoferol/farmacologíaRESUMEN
A modified apparatus is described that provides for the simultaneous bathing of the serosa of an intact piece of isolated guinea pig ileum while allowing infusion of the isolated lumen. The comparative compartmental potency of the opioid agonists morphine, casomorphins, and enkephalins to inhibit electrically driven contractions are described in this system. The rank-order potency for serosally applied opioid agonists was (IC(50) values, nM): [D-Ala(2),N-Me-Phe(4),Gly-ol(5)]-enkephalin (DAMGO) (15)>[D-Ala(2),D-Leu(5)]-enkephalin (DADLE) (35)> or =morphine (46)> or =[D-Ala(2)]-met-enkephalinamide (55)>[D-Ala(2)]-beta-casomorphin[1--4] amide (122)>beta-casomorphin[1--4] amide (940)>met- and leu-enkephalin (>6000). This contrasted to the rank-order potency for the luminally applied opioid agonists: DADLE (63)>DAMGO (135)>[D-Ala(2)]-met-enkephalinamide=morphine (4700)>[D-Ala(2)]-beta-casomorphin[1--4] amide (29000). beta-Casomorphin[1--4] amide, leu-enkephalin and met-enkephalin are mostly inactive when applied luminally. Furthermore, the opioid antagonists, casoxin 4 and [D-Ala(2)]-casoxin 4, when infused into the lumen, significantly overcame the inhibitory effect of morphine added to the serosal side. This model provides an assay and screening system to differentiate between the effects of chemical agents applied via the blood stream (serosa) or food side (lumen) on quiescent or electrically driven gut activity of the nervous plexi or receptor systems of the ileum.
Asunto(s)
Analgésicos Opioides/farmacología , Endorfinas/farmacología , Encefalinas/farmacología , Íleon/efectos de los fármacos , Morfina/farmacología , Músculo Liso/efectos de los fármacos , Antagonistas de Narcóticos/farmacología , Animales , Estimulación Eléctrica , Encefalina Leucina/farmacología , Encefalina Metionina/farmacología , Estudios de Evaluación como Asunto , Femenino , Cobayas , Técnicas In Vitro , Bombas de Infusión , Concentración 50 Inhibidora , Masculino , Contracción Muscular/efectos de los fármacos , Receptores Opioides/efectos de los fármacosRESUMEN
Recent reports suggest modulation of chronic obstructive pulmonary disease by dietary polyunsaturated fatty acids. In the present study, we re-examined this possibility by using an established animal model of pulmonary sensitisation. Adult guinea pigs were fed diets supplemented (10% w/w) with either olive, canola or safflower oil for 4 weeks before sensitising with ovalbumin and continuing on various diets for a further 6 week period. Neither the contraction following ovalbumin challenge, nor the responses to histamine, carbachol and various eicosanoid mediators - prostaglandin F(2 alpha), leukotriene C(4), thromboxane mimetic U44619 - of isolated segments of airway tissue were altered (P>0.05, ANOVA) by the dietary lipid treatment. Lipid analysis showed changes in membrane linoleic acid (18:2n-6) and alpha -linolenic acids (alpha 18:3n-3) in lung phospholipids consistent with dietary intakes. However, no significant further desaturation/elongation of these dietary precursors was evident. Ovalbumin induced contraction was fully reversed by the lipoxygenase inhibitor esculetin whilst indomethacin resulted in a slight increase possibly due to the inhibition of bronchodilator prostanoids. Results confirm that under the conditions employed airway function was not influenced by the variable dietary intakes of n-3 and n-6 PUFA.
Asunto(s)
Bronquios/efectos de los fármacos , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico/farmacología , Análisis de Varianza , Animales , Antioxidantes/farmacología , Carbacol/farmacología , Fármacos Cardiovasculares/farmacología , Suplementos Dietéticos , Dinoprost/farmacología , Relación Dosis-Respuesta a Droga , Ácidos Grasos/metabolismo , Ácidos Grasos Monoinsaturados/farmacología , Cobayas , Histamina/farmacología , Indometacina/farmacología , Leucotrieno C4/farmacología , Ácido Linoleico/farmacología , Metabolismo de los Lípidos , Pulmón/metabolismo , Masculino , Aceite de Oliva , Ovalbúmina/metabolismo , Ovalbúmina/farmacología , Aceites de Plantas/farmacología , Aceite de Brassica napus , Aceite de Cártamo/farmacología , Tromboxanos/farmacología , Umbeliferonas/farmacología , Vasoconstrictores/farmacología , Ácido alfa-Linolénico/farmacologíaRESUMEN
The influence of diets containing gamma-linolenic acid (GLA; 18:3n-6) on sciatic nerve conduction velocity (NCV) was determined in diabetic rats. NCV was lower in diabetic rats fed diets supplemented with olive oil or sunflower seed oil than in nondiabetic rats; rats supplemented with GLA during a 5-wk diabetic period, however, did not exhibit significantly lower NCV. The mean proportion of the phospholipid fatty acid linoleic acid (18:2n-6) was higher in the sciatic nerves of diabetic rats than in the nondiabetic groups irrespective of dietary lipid treatment. Additionally, the proportion of linoleic acid was higher in the diabetic rats fed sunflower oil than in all other groups. Dietary GLA supplementation did not significantly influence the fatty acid composition of nerve membrane phospholipids and there was no obvious correlation between the fatty acid composition of nerve membrane phospholipids and NCV. The content of fructose and glucose in sciatic nerves was higher, whereas that of myo-inositol was lower, in diabetic rats than in nondiabetic rats; however, this was not significantly influenced by dietary GLA. GLA administration did not significantly influence Na(+)-K(+)-exchanging ATPase or ouabain binding activity in sciatic nerve preparations, both of which remained nonsignificantly different in the diabetic and nondiabetic groups. The results suggest that dietary GLA can prevent the deficit in NCV induced by diabetes and that this effect is independent of the nerve phospholipid fatty acid profile, sugar and polyol content, Na(+)-K(+)-exchanging ATPase activity, and ouabain binding. GLA may prevent the deficit in NCV indirectly, possibly by its role as a precursor of vasodilatory prostaglandins. These results confirm that GLA is the active component of evening primrose oil.
Asunto(s)
Diabetes Mellitus Experimental/fisiopatología , Neuropatías Diabéticas/prevención & control , Ácidos Grasos Insaturados/uso terapéutico , Conducción Nerviosa/efectos de los fármacos , Ácido gammalinolénico/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Centrifugación por Gradiente de Densidad , Neuropatías Diabéticas/dietoterapia , Electrofisiología , Ácidos Grasos Esenciales/uso terapéutico , Glucosa/análisis , Ácidos Linoleicos , Masculino , Conducción Nerviosa/fisiología , Oenothera biennis , Ouabaína/química , Fosfolípidos/análisis , Aceites de Plantas , Ratas , Ratas Wistar , Nervio Ciático/fisiopatología , ATPasa Intercambiadora de Sodio-Potasio/análisis , EstreptozocinaRESUMEN
There is considerable interest in the possibility that diet-derived isoflavonoids may help in protection against a number of chronic diseases common in Western society. Based on animal studies, however, concerns have been raised that consumption of isoflavonoids by infants and young children may be undesirable. Clover contains isoflavonoids and therefore may represent, via milk, a source of isoflavonoids in the human diet. In this study the concentrations of daidzein (7, 4'-dihydroxyisoflavone), genistein (5, 7, 4'-trihydroxyisoflavone) and equol (7-hydroxy-(4'-hydroxyphenyl)chroman) were measured using HPLC in cows' milk samples obtained from 76 farms in three Australian states. In addition, concentrations were measured in samples collected from one South Australian factory both before and after pasteurization. Concentrations in all samples were found to be extremely low. The mean daidzein concentration was < 5 ng/ml. Mean genistein concentrations ranged from just detectable (approximately 2 ng/ml) in Victorian samples collected during summer to 20-30 ng/ml in samples from all states collected during spring when isoflavonoid-containing clover is most dominant in pasture. Mean equol concentrations ranged from 45 +/- 10 ng/ml in Victorian farm samples collected during summer to 293 +/- 52 ng/ml in Western Australian samples collected in spring. The mean concentrations of genistein and equol in post-pasteurization samples collected in spring were approximately double those for samples collected in autumn. Pasteurization had no effect on isoflavonoid concentrations. We conclude that the concentrations of isoflavonoids in Australian cows' milk are low and are therefore unlikely to have any pronounced biological effects in human consumers.
Asunto(s)
Bovinos/metabolismo , Flavonoides/análisis , Leche/química , Animales , Australia , Cromanos/análisis , Cromatografía Líquida de Alta Presión , Equol , Femenino , Genisteína/análisis , Calor , Isoflavonas/análisis , Estaciones del AñoRESUMEN
1. 5-Hydroxytryptamine (5-HT) exerts both contractile and relaxant effects in the marmoset isolated aorta, actions that are unaffected by the 5-HT2 antagonist ketanserin. The aim of the present study was to define the receptors mediating the contractile activity of 5-HT in the marmoset aorta. 2. Contractile responses were elicited in aortic rings that were either: (i) precontracted submaximally with the thromboxane A2 agonist U44069 in order to amplify the responses; or (ii) exposed to N(omega)-nitro-L-arginine (100 micromol/L) plus LY 53857 (0.1 micromol/L; a 5-HT2 receptor antagonist shown previously to inhibit relaxation). The effect of 5-HT on adenosine 3',5'-cyclic monophosphate (cAMP) formation was also investigated. 3. The effects of agonists and antagonists comprised: (i) agonist potencies in the order 5-carboxamidotryptamine > 5-HT > sumatriptan > 8-hydroxy-2-(di-n-propylamino)tetralin; (ii) inhibition of contractile action of 5-HT by the 5-HT1D antagonist GR 127935; (iii) a contractile response to methysergide; (iv) a lack of effect of tropisetron, an antagonist of 5-HT3 and 5-HT4 receptors; and (v) inhibition of forskolin-stimulated cAMP formation by 5-HT (in the presence of LY 53857), indicative of negative coupling to adenylate cyclase. 4. The above effects fulfill the criteria for a 5-HT1-like receptor. In view of the previous finding that this contractile response is insensitive to ketanserin, it is concluded that the contractile effects of 5-HT in the marmoset aorta are mediated exclusively by a 5-HT1-like receptor.
Asunto(s)
Aorta/efectos de los fármacos , AMP Cíclico/metabolismo , Receptores de Serotonina/efectos de los fármacos , Serotonina/farmacología , Vasoconstricción/efectos de los fármacos , Animales , Aorta/fisiología , Arterias/efectos de los fármacos , Callithrix , Endoperóxidos de Prostaglandinas Sintéticos/farmacología , Receptores de Serotonina/metabolismoRESUMEN
Young adult male Hooded Wistar rats were rendered diabetic by administration of streptozotocin and maintained for 5 weeks on a diet containing either 6% olive oil as the total source of fat (OO diet), or purified gamma-linolenic acid (GLA) at a concentration of 0.5% with the remaining 5.5% provided by olive oil (GLA diet). Rats were treated with the angiotensin converting inhibitor, cilazapril, administered in the drinking water at a dose of 20 mg kg-1 body weight day-1. For the OO diet groups, sciatic nerve conduction velocity (NCV) in diabetic rats was reduced by 32% (p < 0.01) in comparison with nondiabetic (vehicle-treated) rats and 27.5% (p < 0.05) in comparison with diabetic rats treated with cilazapril. Diabetic, cilazapril-treated rats showed no reduction in NCV. For the nondiabetic, diabetic, and diabetic plus cilazapril groups fed GLA, the NCV was not significantly different, indicating that dietary GLA also prevented the deficit in the NCV induced by the diabetic state. Analysis of the sciatic nerve endoneurial phospholipid fatty acids revealed a significant reduction in the proportion of GLA and an elevation in the proportion of linoleic acid in the diabetic groups compared with the nondiabetic groups and this was independent of the cilazapril treatment or the dietary lipid supplement. Sciatic nerve myo-inositol content was unaltered while mannose, fructose, glucose, and sorbitol levels were elevated in the diabetic groups and these changes were independent of the cilazapril treatment or the dietary lipid supplement. These results indicate that in the rat, cilazapril treatment or dietary GLA, at the doses tested, are effective in preventing the deficit in the NCV induced by diabetes.
Asunto(s)
Cilazapril/uso terapéutico , Diabetes Mellitus Experimental/fisiopatología , Neuropatías Diabéticas/prevención & control , Conducción Nerviosa/efectos de los fármacos , Fosfolípidos/metabolismo , Nervio Ciático/fisiopatología , Ácido gammalinolénico/uso terapéutico , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Animales , Neuropatías Diabéticas/fisiopatología , Ácidos Grasos/análisis , Masculino , Conducción Nerviosa/fisiología , Aceite de Oliva , Fosfolípidos/análisis , Fosfolípidos/química , Aceites de Plantas , Ratas , Ratas Wistar , Nervio Ciático/efectos de los fármacos , Nervio Ciático/fisiología , Ácido gammalinolénico/administración & dosificaciónRESUMEN
Consumption of soy products has been linked to a reduced mortality and morbidity from a number of cancers. Genistein, one of the principal soy isoflavones, has been shown to inhibit the growth of a number of tumour cell lines in vitro; however, a role of genistein in retarding tumour growth in vivo is less well documented. In this study, in addition to examining the effects of genistein on the growth of murine B16 melanoma cells in vitro, we have examined the effects of feeding a genistein-rich diet on s.c. growth of these tumour cells in mice. In vitro, the melanoma cells showed an increase in sensitivity to genistein with increasing time of exposure, culminating in a 50% growth inhibition (IC50) at 12.5 microM after 7 days. Genistein at 25 microM induced micronucleus formation after 24 hr and at concentrations as low as 2.5 microM induced morphological changes indicative of differentiation. Growth of solid tumours implanted into female C57BL/6J mice was inhibited by 50% when mice were fed genistein for 1 week before and for 1 week after inoculation with B16 melanoma cells. Plasma genistein concentrations at the time of tumour removal were 1.1 microM, which is similar to levels reported in humans consuming diets high in soybeans or soybean products, while control animals had no detectable genistein in plasma. Our results provide additional in vivo evidence suggesting that genistein retards the growth of implanted tumours, adding further to studies suggesting that this isoflavonoid is a biologically active component of soy foods.
Asunto(s)
Antineoplásicos/farmacología , Genisteína/farmacología , Inhibidores de Crecimiento/farmacología , Melanoma/fisiopatología , Animales , Antineoplásicos/sangre , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Citocalasina B/farmacología , Relación Dosis-Respuesta a Droga , Etopósido/farmacología , Femenino , Genisteína/sangre , Inhibidores de Crecimiento/sangre , Melanoma/patología , Ratones , Ratones Endogámicos C57BL , Trasplante de Neoplasias , Factores de Tiempo , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
1. Na+/H+ antiporter/exchange activity (NHE) in human cheek epithelial cells was assessed in 288 female twins and siblings. The genetic contribution of factors to NHE activity was assessed in 128 matched twin pairs (76 monozygotic (MZ); 52 dizygotic (DZ)). 2. There was a small reduction in NHE with age and body mass index. The significant correlations (+/-their standard error (SE)) within MZ and DZ pairs of twins were 0.54 +/- 0.08 and 0.26 +/- 0.13, respectively, implying that genetic factors accounted for 54% of the variance in age-adjusted NHE. There was no cross-sectional relationship between NHE and measures of blood pressure. Based on within-pair differences, however, there was a weak negative association (r = 0.22; P < 0.05) between mean arterial pressure and NHE. 3. It remains to be determined whether NHE in cheek cells is associated with blood pressure tracking over time in young females.
Asunto(s)
Hipertensión/genética , Intercambiadores de Sodio-Hidrógeno/genética , Sodio/metabolismo , Adolescente , Adulto , Presión Sanguínea/genética , Separación Celular , Niño , Estudios Transversales , Epitelio/metabolismo , Femenino , Humanos , Hipertensión/metabolismo , Transporte Iónico/genética , Mucosa Bucal/citología , Mucosa Bucal/metabolismoRESUMEN
Several cardiovascular risk factors including, hypercholesterolaemia and hypertension, lead to diseased blood vessels due to endothelial cell dysfunction. Recent studies also indicate that such alterations in blood vessel function may involve free radical related mechanism(s). Therefore, in the present study, two different preparations of palm oils with variable antioxidant profiles, as well as a purified antioxidant fraction extracted from unprocessed palm oil (tocotrienol-rich-factor; TRF), were tested for their ability to influence blood vessel dysfunction in the spontaneously hypertensive rat (SHR). Adult SHRs were fed a synthetic diet supplemented (5% w/w) with either physically refined palm oil (PO), golden palm cooking oil (Nutrolein; GPO) or olive oil (OO; control diet). Antioxidant rich diet (TRF diet) was prepared by supplementing the OO diet with 0.2% (w/w) TRF. After 12 weeks of pre-feeding, segments of thoracic aorta were used to evaluate vascular function. Compared to the normotensive Wistar-Kyoto (WKY) control rats, aortic rings from the SHR showed impaired endothelium dependent relaxation to acetylcholine (ACh) which was restored by dietary TRF (p<0.05, ANOVA and Tukey's test). In addition, the paradoxical increase in tension in control hypertensive vessels observed at higher doses of ACh was prevented by TRF and also by the PO and GPO diets. Although the development of thromboxane-like constrictor response, after the inhibition of nitric oxide in hypertensive vessels, was unaffected by test diets, both TRF and GPO feeding prevented the amplification of this unwanted constriction by a threshold dose (7.2x10-10 M) of noradrenaline. Results suggest a modulatory role for minor constituents of edible oils and are in agreement with the recently reported benefits of natural antioxidants against cardiovascular diseases.
Asunto(s)
Alimentos , Promoción de la Salud , Genisteína , Humanos , Isoflavonas , Fenómenos Fisiológicos de la NutriciónRESUMEN
Proton-dependent, ethylisopropylamiloride (EIPA)-sensitive Na+ uptake (Na+/H+ antiporter) studies were performed to examine if saliva, and ionophores which alter cellular electrolyte balance, could influence the activity of the cheek cell Na+/H+ antiporter. Using the standard conditions of 1 mmol/l Na+, and a 65:1 (inside:outside) proton gradient in the assay, the uniport ionophores valinomycin (K+) and gramicidin (Na+) increased EIPA-sensitive Na+ uptake by 177% (p < 0.01) and 227% (p < 0.01), respectively. The dual antiporter ionophore nigericin (K(+)-H+) increased EIPA-sensitive Na+ uptake by 654% (p < 0.01), with maximal Na+ uptake achieved by 1 min and at an ionophore concentration of 50 mumol/l, with an EC50 value 6.4 mumol/l. Pre-incubation of cheek cells with saliva or the low molecular weight (MW) components of saliva (saliva activating factors, SAF) for 2 h at 37 degrees C, also significantly stimulated EIPA-sensitive Na+ uptake. This stimulation could be mimicked by pre-incubation with 25 mmol/l KCl or K(+)-phosphate buffer. Pre-incubating cheek cells with SAF and the inclusion of 20 mumol/l nigericin in the assay, produced maximum EIPA-sensitive Na+ uptake. After pre-incubation with water, 25 mmol/l K(+)-phosphate or SAF, with nigericin in all assays, the initial rate of proton-gradient dependent, EIPA-sensitive Na+ uptake was saturable with respect to external Na+, with Km values of 0.9, 1.7, and 1.8 mmol/l, and Vmax values of 13.4, 25.8, and 31.1 nmol/mg protein/30 sec, respectively. With 20 mumol/l nigericin in the assay, Na+ uptake was inhibited by either increasing the [K+]o in the assay, with an ID50 of 3 mmol/l. These results indicate that nigericin can facilitate K+i exchange for H+o and the attending re-acidification of the cheek cell amplifies 22Na+ uptake via the Na+/H+ antiporter. The degree of stimulation of proton-dependent, EIPA-sensitive Na+ uptake is therefore dependent, in part, on the intracellular [K+]i.
Asunto(s)
Electrólitos/metabolismo , Mucosa Bucal/metabolismo , Nigericina/farmacología , Saliva/fisiología , Intercambiadores de Sodio-Hidrógeno/metabolismo , Adulto , Amilorida/análogos & derivados , Amilorida/farmacología , Mejilla , Gramicidina/farmacología , Humanos , Técnicas In Vitro , Ionóforos/farmacología , Cinética , Potasio/farmacología , Sodio/metabolismo , Sodio/farmacología , Intercambiadores de Sodio-Hidrógeno/efectos de los fármacos , Valinomicina/farmacologíaRESUMEN
Rodent models have been used to study the anticarcinogenic properties of the soy isoflavones, particularly genistein, but there is little information regarding the pharmacokinetics of the absorption and excretion of genistein. In this study, rats were given a single oral dose of genistein (20 mg/kg body weight) or an equivalent dose of its glycone forms, as an isoflavone-rich soy extract. Concentrations of genistein were measured in plasma, urine and feces at intervals up to 48 h after dosing. Plasma genistein concentration at 2 h after dosing was 11.0 +/- 2.3 mumol/L in genistein-treated rats compared with 4.93 +/- 0.22 mumol/L (P = 0.025) in soy extract-treated rats, but there were no significant differences at 8 h and later times. The mean urinary excretion rate during the first 2 h after dosing was more than 10 times higher in the genistein group compared with the soy extract group (0.27 +/- 0.08 mumol/h and 0.020 +/- 0.011 mumol/h, respectively, P = 0.017) but the percentage of dose recovered in urine over 48 h was not different between groups (19.9 +/- 2.4% genistein treated; 17.5 +/- 1.1% soy extract treated). There were no significant differences between groups in the recovery of genistein in feces (21.9 +/- 2.8% and 21.1 +/- 2.5% of dose, respectively). Only 6.1 +/- 0.9% of the daidzein from the soy extract was recovered in the feces. The results suggest that the extent of absorption of genistein is similar for the glycone and aglycone forms. Although higher initial plasma concentrations may be achieved with the aglycone, similar long-term concentrations exist for both forms of isoflavone.
Asunto(s)
Isoflavonas/farmacocinética , Proteínas de Vegetales Comestibles/farmacocinética , Animales , Relación Dosis-Respuesta a Droga , Heces/química , Genisteína , Absorción Intestinal/fisiología , Isoflavonas/análisis , Isoflavonas/metabolismo , Isoflavonas/orina , Masculino , Proteínas de Vegetales Comestibles/análisis , Proteínas de Vegetales Comestibles/orina , Ratas , Ratas Wistar , Proteínas de Soja , Factores de TiempoRESUMEN
1. Human cheek cell Na+/H+ antiporter activity (measured as the rate of proton-dependent 22Na+ uptake) was determined in seven normotensive (NT) and four hypertensive (HT) subjects following preincubation of cheek cells with a low molecular weight fraction isolated from NT saliva together with the ionophore, nigericin. 2. Cheek cells preincubated in this manner exhibited greater Na+/H+ antiporter activity with the mean values being 4.2 nmol Na+.mg protein.5 min for the NT group and 1.7 for the HT group. 3. It is possible that stimulation of Na+ transport is due to cellular accumulation of K+ ions during preincubation which, in the presence of the K+/H+ selective ionophore, nigericin, can cause cellular reacidification promoting further 22Na+ uptake via the Na+/H+ antiporter.
Asunto(s)
Mejilla , Hipertensión/metabolismo , Saliva/citología , Intercambiadores de Sodio-Hidrógeno/metabolismo , Adulto , Transporte Biológico Activo/fisiología , Fraccionamiento Celular , Femenino , Humanos , Hipertensión/diagnóstico , Hipertensión/patología , Ionóforos/química , Masculino , Persona de Mediana Edad , Peso Molecular , Nigericina/química , Sodio/metabolismoRESUMEN
Treatment of spontaneously hypertensive rats (SHR) with alpha-adrenoceptor antagonists failed to alter the development of hypertension in this animal model. However, agents such as captopril (CAP) and losartan (LOS) which interfere with the renin-angiotensin system effectively prevented the development of hypertension. When tolerance occurred in the presence of doxazosin (DOX) or phenoxybenzamine, there was an enhanced sensitivity to the blood pressure lowering influence of LOS. In the presence of CAP, at a dose that did not retard the development of blood pressure in the SHR, DOX treatment significantly offset the development of hypertension in this strain. These results suggest that a functional tolerance to agents that interfere with the sympathetic nervous system is mediated by the renin-angiotensin system. Angiotensin-converting enzyme inhibition was associated with a normalization of the enhanced contraction of the mesenteric vascular bed seen in preparations from the SHR and a suppression in the development of the vascular amplifier. The results suggest that the sympathetic nervous system is unable to maintain an elevated blood pressure in the SHR during interference with the functioning of the renin-angiotensin system. Conversely, under conditions of alpha-adrenoceptor blockade, angiotensin II can maintain an elevated blood pressure in the SHR.
Asunto(s)
Antagonistas Adrenérgicos alfa/uso terapéutico , Angiotensina II/fisiología , Hipertensión/tratamiento farmacológico , Animales , Compuestos de Bifenilo/administración & dosificación , Compuestos de Bifenilo/uso terapéutico , Presión Sanguínea , Captopril/administración & dosificación , Captopril/uso terapéutico , Doxazosina/administración & dosificación , Doxazosina/uso terapéutico , Tolerancia a Medicamentos , Hipertensión/fisiopatología , Imidazoles/administración & dosificación , Imidazoles/uso terapéutico , Losartán , Norepinefrina/farmacología , Fenoxibenzamina/administración & dosificación , Fenoxibenzamina/uso terapéutico , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Tetrazoles/administración & dosificación , Tetrazoles/uso terapéuticoRESUMEN
1. The levels of the neurotrophic factor, nerve growth factor (NGF) in the mesenteric vascular bed of the spontaneously hypertensive rat (SHR) were greater than those in the corresponding vascular bed of normotensive Wistar-Kyoto rats (WKY). 2. Administration of angiotensin II (200 ng/kg per min, by minipump) for 2 weeks to juvenile WKY rats increased the levels of NGF in the mesenteric vasculature to those seen in untreated SHR. 3. Administration of the angiotensin II receptor antagonists losartan (30 mg/kg per day, p.o.) or PD144277 (10 mg/kg per day, p.o.) to juvenile SHR for 4 weeks reduced the levels of NGF such that they were indistinguishable from the values obtained for normotensive WKY rats. 4. The results confirm the elevated level of NGF in the mesenteric vasculature of the SHR and suggest that angiotensin II may play a role in regulating the abnormal concentrations of the protein in this tissue.
Asunto(s)
Antagonistas de Receptores de Angiotensina , Antihipertensivos/farmacología , Hipertensión/tratamiento farmacológico , Factores de Crecimiento Nervioso/biosíntesis , Sistema Renina-Angiotensina/fisiología , Angiotensina II/administración & dosificación , Angiotensina II/farmacología , Animales , Antihipertensivos/administración & dosificación , Antihipertensivos/uso terapéutico , Compuestos de Bifenilo/administración & dosificación , Compuestos de Bifenilo/farmacología , Hipertensión/fisiopatología , Imidazoles/administración & dosificación , Imidazoles/farmacología , Bombas de Infusión , Losartán , Arterias Mesentéricas/efectos de los fármacos , Arterias Mesentéricas/metabolismo , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Sistema Renina-Angiotensina/efectos de los fármacos , Tetrazoles/administración & dosificación , Tetrazoles/farmacologíaRESUMEN
The effect of dietary fish oils on development of hypertension and vascular response in vitro were studied in rats and a primate. Dietary fish oils (MaxEPA and an n-3 ethyl ester concentrate of higher EPA and DHA content) were administered to spontaneously hypertensive (SHR), stroke-prone spontaneously hypertensive (SHR-SP) and a backcross of SHR and Wistar Kyoto (SHR/WKY) rats from 4-16 weeks of age. Blood pressure was monitored during the feeding period and vascular responses measured in the aorta and mesenteric vascular bed in vitro. Depending on the strain of rat used and the composition of the fish oil the attenuation in blood pressure was 10-26 mmHg. Fish oils attenuated the response mediated by sympathetic nerve stimulation or intralumenal norepinephrine in the perfused mesenteric vascular bed preparation from the SHR. This attenuation was more pronounced for fish oils enriched with eicosapentaenoic acid and docosahexaenoic acid and was more prominent in the SHR and SHR/WKY backcross than it was in the SHR-SP. Prostanoid synthesis or nitric oxide modulation of alpha-adrenoceptor responses were shown not to be involved in the attenuation of vascular responses produced by fish oil. The maximum contraction of aortic ring preparations in response to norepinephrine (NE) was significantly smaller in SHR than WKY rats fed olive oil and for SHR rats maintained on fish oils the contraction was close to WKY olive oil values. Evidence was obtained also for a modulation of vasoconstrictor responses by dietary fish oils in the perfused mesenteric bed of the marmoset monkey.